The country’s Medicines and Healthcare products Regulatory Agency’s (MHRA) Yellow Card scheme, the UK’s official system for ...

Study finds the GLP-1 drug liraglutide reduced migraine days by almost 50% in patients with obesity, with quality of life ...

The drug is now available for prescription in New Zealand but there are clouds to go along with the silver linings - such as ...

CVS Caremark will stop covering Eli Lilly’s Zepbound. Wegovy, the GLP-1 medication to treat obesity from Lilly competitor ...

A novel medication out of Sweden has shown some of the same promise in melting belly fat — without making your stomach churn.

I hear a lot of talk around our small town when someone becomes noticeably thinner. “He sure has lost a lot of weight.” “Did ...

Both semaglutide and tirzepatide for type 2 diabetes and weight loss are GLP-1 agonists, meaning they mimic the hormone.

Health insurance companies, including CVS Caremark, are altering coverage for GLP-1 weight loss medications like Zepbound, ...

The first study to put two GLP-1 weight loss drugs head-to-head found Zepbound helped people lose more weight than Wegovy.

A report from the human resources trade group SHRM, which just released its 2025 Benefits Survey—the most comprehensive ...

Taking to platforms including Reddit and Telegram for guidance, buyers import small quantities, often described as research ...

As demand for obesity drugs rises, questions emerge over approvals granted without India-specific safety and efficacy trials.